These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3921975)

  • 41. Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension.
    Adeagbo AS; Zhang X; Patel D; Joshua IG; Wang Y; Sun X; Igbo IN; Oriowo MA
    J Hypertens; 2005 May; 23(5):1025-36. PubMed ID: 15834289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Central and peripheral adrenergic mechanisms in the development of deoxycorticosterone-saline hypertension in rats.
    Reid JL; Zivin JA; Kopin IJ
    Circ Res; 1975 Nov; 37(5):569-79. PubMed ID: 1192556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phorbol ester-induced contraction through p38 mitogen-activated protein kinase is diminished in aortas from DOCA-salt hypertensive rats.
    Lee CK; Kim J; Won KJ; Lee HM; Kim HJ; Roh HY; Park HJ; Shin HS; Park TK; Kim B; Lee SM
    Arch Pharm Res; 2006 Nov; 29(11):1024-31. PubMed ID: 17146972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary potassium, blood pressure and peripheral adrenergic responsiveness in the deoxycorticosterone acetate-salt rat.
    Soltis EE; Iloeje E; Katovich MJ
    Clin Exp Hypertens A; 1988; 10(3):447-66. PubMed ID: 3359660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.
    Lamprecht F; Richardson JS; Williams RB; Kopin IJ
    J Neural Transm; 1977; 40(2):149-58. PubMed ID: 323422
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impairment of neurally-mediated vasoconstriction in DOCA-salt hypertensive dogs.
    Hamed AT; Lokhandwala MF
    Clin Exp Hypertens A; 1982; 4(6):867-81. PubMed ID: 6284412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is functional upregulation of the 5-HT2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent?
    Watts SW; Harris B
    Gen Pharmacol; 1999 Dec; 33(6):439-47. PubMed ID: 10647769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced contraction to 5-hydroxytryptamine is not due to "unmasking" of 5-hydroxytryptamine(1b) receptors in the mesenteric artery of the deoxycorticosterone acetate-salt rat.
    Banes AK; Watts SW
    Hypertension; 2001 Oct; 38(4):891-5. PubMed ID: 11641304
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced release of endothelium-derived relaxing factor in mineralocorticoid hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Hypertension; 1992 Sep; 20(3):304-13. PubMed ID: 1516949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sodium pump activity and calcium relaxation in vascular smooth muscle of deoxycorticosterone acetate-salt rats.
    Soltis EE; Field FP
    Hypertension; 1986 Nov; 8(11):1032-9. PubMed ID: 2429928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decreased vascular glucose transporter expression and glucose uptake in DOCA-salt hypertension.
    Atkins KB; Johns D; Watts S; Clinton Webb R; Brosius FC
    J Hypertens; 2001 Sep; 19(9):1581-7. PubMed ID: 11564977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronary artery reactivity in deoxycorticosterone acetate hypertensive rats.
    Hagen EC; Webb RC
    Am J Physiol; 1984 Sep; 247(3 Pt 2):H409-14. PubMed ID: 6383078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mineralocorticoids modulate central angiotensin II receptors in rats.
    Wilson KM; Sumners C; Hathaway S; Fregly MJ
    Brain Res; 1986 Sep; 382(1):87-96. PubMed ID: 3768684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS; Nunes KP; Giachini FR; Lima VV; Carneiro ZN; Nogueira EF; Leite R; Ergul A; Rainey WE; Clinton Webb R; Tostes RC
    J Sex Med; 2008 Dec; 5(12):2793-807. PubMed ID: 18823320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Norepinephrine sensitivity and membrane potentials of caudal arterial muscle in DOCA-salt, Dahl, and SHR hypertension in rat.
    Hermsmeyer K; Abel PW; Trapani AJ
    Hypertension; 1982; 4(3 Pt 2):49-51. PubMed ID: 6279507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chlorthalidone-modulated vascular responses to vasodilator stimuli in DOCA-salt hypertensive rats.
    Bissoli NS; Vasquez EC; Cabral AM
    Pharmacol Res; 1996 Jan; 33(1):47-54. PubMed ID: 8817646
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of cyclopiazonic acid on intracellular Ca2+ in aortic smooth muscle cells from DOCA-hypertensive rats.
    Tostes RC; Wilde DW; Bendhack LM; Webb RC
    Braz J Med Biol Res; 1997 Feb; 30(2):257-67. PubMed ID: 9239314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.